| Shire to Purchase Substantially All Pervasis Assets to Fortify Regenerative ... - Genetic Engineering News |
|
|
Genetic Engineering News Shire says that it will initially focus on completing a Phase II program in end-stage renal disease (ESRD) patients to address maturation and maintenance of arteriovenous (AV) access for hemodialysis patients. “There are currently no approved therapies |